Inovio Pharma (INO) Tops Q1 EPS by 31c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.10 --0%
EPS Growth %: +36.1%
Financial Fact:
Grant and miscellaneous revenue: 9.41M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: +36.1%
Financial Fact:
Grant and miscellaneous revenue: 9.41M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q1 EPS of $0.16, $0.31 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $110 thousand versus the consensus estimate of $300 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- Carvana (CVNA) PT Lowered to $85 at RBC Capital
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
